RSS-Feed abonnieren
PDF herunterladen
DOI: 10.4103/ijmpo.ijmpo_244_17
Early-onset unusual second cancers – More nightmare in a resource-constrained setting: A report from Lagos, Nigeria
Financial support and sponsorship Nil.
Abstract
Second cancers are not quite common in the pediatric age group, and they are described as histologically distinct cancers from the initial cancer. This study aimed to report the occurrence of second cancers among a cohort of children treated for cancers in Lagos, Nigeria. The report was compiled from the Department of Pediatrics, Lagos University Teaching Hospital, between January 2015 and June 2017. Ethical approval was obtained from the hospital's Research and Ethics Committee. Parental consent was also obtained to publish the reports. A total of one hundred and seventy nine children were treated in the period under review for various malignancies and all those on follow up were included. Two children developed second cancers within 15 months of completing treatment. Extensive genetic testing and surveillance is advocated for children treated in resource-limited settings.
Publikationsverlauf
Artikel online veröffentlicht:
08. Juni 2021
© 2019. Indian Society of Medical and Paediatric Oncology. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/).
Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India
-
References
- 1 Neugut AT, Meadows AT, Robinson E. editors. Multiple Primary Cancers. Philadelphia: Lippincott Williams & Wilkins; 1999; p: 3-10
- 2 Neglia JP, Friedman DL, Yasui Y, Mertens AC, Hammond S, Stovall M. et al. Second malignant neoplasms in five-year survivors of childhood cancer: Childhood cancer survivor study. J Natl Cancer Inst 2001; 93: 618-29
- 3 Bhatia S, Robison LL, Oberlin O, Greenberg M, Bunin G, Fossati-Bellani F. et al. Breast cancer and other second neoplasms after childhood Hodgkin's disease. N Engl J Med 1996; 334: 745-51
- 4 Meadows AT. Risk factors for second malignant neoplasms: Report from the late effects study group. Bull Cancer 1988; 75: 125-30
- 5 Hawkins MM, Wilson LM, Stovall MA, Marsden HB, Potok MH, Kingston JE. et al. Epipodophyllotoxins, alkylating agents, and radiation and risk of secondary leukaemia after childhood cancer. BMJ 1992; 304: 951-8
- 6 Nichols CR, Breeden ES, Loehrer PJ, Williams SD, Einhorn LH. Secondary leukemia associated with a conventional dose of etoposide: Review of serial germ cell tumor protocols. J Natl Cancer Inst 1993; 85: 36-40
- 7 Neglia JP, Meadows AT, Robison LL, Kim TH, Newton WA, Ruymann FB. et al. Second neoplasms after acute lymphoblastic leukemia in childhood. N Engl J Med 1991; 325: 1330-6
- 8 Mody R, Li S, Dover DC, Sallan S, Leisenring W, Oeffinger KC. et al. Twenty-five-year follow-up among survivors of childhood acute lymphoblastic leukemia: A report from the childhood cancer survivor study. Blood 2008; 111: 5515-23
- 9 Cohen RJ, Curtis RE, Inskip PD, Fraumeni JFJr. The risk of developing second cancers among survivors of childhood soft tissue sarcoma. Cancer 2005; 103: 2391-6